These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16256702)

  • 1. Intranasal absorption of granulocyte-colony stimulating factor (G-CSF) from powder formulations, in sheep.
    Gill IJ; Fisher AN; Farraj N; Pitt CG; Davis SS; Illum L
    Eur J Pharm Sci; 1998 Jan; 6(1):1-10. PubMed ID: 16256702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption of recombinant human granulocyte colony-stimulating factor (rhG-CSF) from rat nasal mucosa.
    Machida M; Sano K; Arakawa M; Hayashi M; Awazu S
    Pharm Res; 1993 Sep; 10(9):1372-7. PubMed ID: 7694272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a dosing solution on the nasal absorption of non-glycosylated recombinant human granulocyte colony-stimulating factor in rats.
    Nomura H; Akamisaka S; Maruyama K
    Biol Pharm Bull; 1996 Nov; 19(11):1490-3. PubMed ID: 8951170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary absorption of recombinant human granulocyte colony-stimulating factor (rhG-CSF) after intratracheal administration to rats.
    Machida M; Hayashi M; Awazu S
    Biol Pharm Bull; 1996 Feb; 19(2):259-62. PubMed ID: 8850318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary delivery of powders and solutions containing recombinant human granulocyte colony-stimulating factor (rhG-CSF) to the rabbit.
    Niven RW; Lott FD; Ip AY; Cribbs JM
    Pharm Res; 1994 Aug; 11(8):1101-9. PubMed ID: 7971709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary absorption of recombinant methionyl human granulocyte colony stimulating factor (r-huG-CSF) after intratracheal instillation to the hamster.
    Niven RW; Lott FD; Cribbs JM
    Pharm Res; 1993 Nov; 10(11):1604-10. PubMed ID: 7507241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption of recombinant human granulocyte colony-stimulating factor (rhG-CSF) and blood leukocyte dynamics following intranasal administration in rabbits.
    Watanabe Y; Matsumoto Y; Yamaguchi M; Kikuchi R; Takayama K; Nomura H; Maruyama K; Matsumoto M
    Biol Pharm Bull; 1993 Jan; 16(1):93-5. PubMed ID: 7690293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of rhG-CSF absorption kinetics after subcutaneous administration using a modified Wagner-Nelson method with a nonlinear elimination model.
    Hayashi N; Aso H; Higashida M; Kinoshita H; Ohdo S; Yukawa E; Higuchi S
    Eur J Pharm Sci; 2001 May; 13(2):151-8. PubMed ID: 11297899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles.
    Dyer AM; Hinchcliffe M; Watts P; Castile J; Jabbal-Gill I; Nankervis R; Smith A; Illum L
    Pharm Res; 2002 Jul; 19(7):998-1008. PubMed ID: 12180553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal bioavailability of insulin powder formulations: effect of permeation enhancer-to-protein ratio.
    Lee WA; Narog BA; Patapoff TW; Wang YJ
    J Pharm Sci; 1991 Aug; 80(8):725-9. PubMed ID: 1791529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal delivery of recombinant human growth hormone (somatropin) in sheep using chitosan-based powder formulations.
    Cheng YH; Dyer AM; Jabbal-Gill I; Hinchcliffe M; Nankervis R; Smith A; Watts P
    Eur J Pharm Sci; 2005 Sep; 26(1):9-15. PubMed ID: 15970435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamics and pharmacokinetics of recombinant human granulocyte colony-stimulating factor (rhG-CSF) after administration of a rectal dosage vehicle.
    Watanabe Y; Kiriyama M; Ito R; Kikuchi R; Mizufune Y; Nomura H; Miyazaki M; Matsumoto M
    Biol Pharm Bull; 1996 Aug; 19(8):1059-63. PubMed ID: 8874816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal delivery of morphine.
    Illum L; Watts P; Fisher AN; Hinchcliffe M; Norbury H; Jabbal-Gill I; Nankervis R; Davis SS
    J Pharmacol Exp Ther; 2002 Apr; 301(1):391-400. PubMed ID: 11907197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor in the rat. Single and multiple dosing studies.
    Tanaka H; Kaneko T
    Drug Metab Dispos; 1991; 19(1):200-4. PubMed ID: 1708329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enteral bioavailability of human granulocyte colony stimulating factor conjugated with poly(ethylene glycol).
    Jensen-Pippo KE; Whitcomb KL; DePrince RB; Ralph L; Habberfield AD
    Pharm Res; 1996 Jan; 13(1):102-7. PubMed ID: 8668656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of two recombinant human granulocyte colony-stimulating factor glycoforms. Pharmacokinetic and activity studies of single-dose administration in mice.
    Rotondaro L; De Paolis E; Ferrero D; D'Alatri L; Raucci G; Fabbri A; Gerwig GJ; Kamerling JP; Mariani MF; Mele A; De Santis R
    Mol Biotechnol; 1999 Apr; 11(2):117-28. PubMed ID: 10464766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal Absorption of Macromolecules from Powder Formulations and Effects of Sodium Carboxymethyl Cellulose on Their Absorption.
    Tanaka A; Furubayashi T; Matsushita A; Inoue D; Kimura S; Katsumi H; Sakane T; Yamamoto A
    PLoS One; 2016; 11(9):e0159150. PubMed ID: 27598527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioequivalence of two recombinant granulocyte colony-stimulating factor products after subcutaneous injection in healthy volunteers.
    Lubenau H; Sveikata A; Gumbrevicius G; Macijauskiene J; Fokas V; Kazlauskas S; Janulionis V
    Int J Clin Pharmacol Ther; 2009 Apr; 47(4):275-82. PubMed ID: 19356394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability of granulocyte colony-stimulating factor administered enterally to suckling mice.
    Gersting JA; Kotto-Kome CA; Du Y; Christensen RD; Calhoun DA
    Pharmacol Res; 2003 Dec; 48(6):643-7. PubMed ID: 14527831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic/pharmacodynamic analysis of neutrophil proliferation induced by recombinant granulocyte colony-stimulating factor (rhG-CSF): comparison between intravenous and subcutaneous administration.
    Sugiura M; Yamamoto K; Sawada Y; Iga T
    Biol Pharm Bull; 1997 Jun; 20(6):684-9. PubMed ID: 9212991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.